Group items tagged

Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector. The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies. Beginning August, the DHSC is set to claw back the amount. McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies. Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability of many pharmacies. "Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of their making, the Department of Health is jeopardising the foundation of local healthcare delivery," McQuillan criticised. Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector. The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies. Beginning August, the DHSC is set to claw back the amount. McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies. Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability of many pharmacies. "Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of thei

Nestled in the heart of a bustling high street and a housing estate, at Lincoln Pharmacy, part of Mildcare Ltd Group, in Tower Hamlets in London, the scene is a testament to resilience and innovation, where queues of people seek aid from a pharmacy technician stationed behind a glass window-a symbol of the enduring impact of the pandemic. Amidst the array of modern amenities at the pharmacy stands Atulkumar Patel, the proprietor and Independent Prescriber (IP) at Lincoln Pharmacy, whose vision has propelled the establishment into a beacon of progressive healthcare. Owner of two Pharmacies, Patel's team of 20 dispenses an average of 20,000 prescriptions monthly, maintaining an NHS/OTC split of 80/20. Recipient of the prestigious Independent Prescriber of the Year award at the Pharmacy Business Awards 2023, Patel reflects on the pivotal moment when his pharmacy pioneered the rollout of COVID-19 vaccine jabs within the community. "When doctors' doors closed, pharmacy was the only place where people could get help and care," Patel recounts, emphasising the pivotal role pharmacies played during the crisis. Patel's dedication during the pandemic extended beyond mere service provision; it was about showcasing the untapped potential of pharmacies.

Southwark Crown Court on Thursday sentenced two pharmacists to two years of imprisonment each, suspended for 24 months, after they were found guilty of selling 'industrial' quantities of Class C controlled drugs. Mandip Sidhu (47) of Littleover, Derby and Nabeil Nasr (42) of Cheadle, Greater Manchester, pleaded guilty at an earlier hearing following an investigation by the Criminal Enforcement Unit of the Medicines and Healthcare Products Regulatory Authority (MHRA). Both Sidhu and Nasr were pharmacists registered with the General Pharmaceutical Council at the time of the offenses, which took place between May 2013 and June 2017. Sidhu was the director of Pharmaceutical Health Limited (PHL) in Derby, while Nasr owned several pharmacies across the North West of England. Sidhu was sentenced to two years imprisonment on each of five counts of supplying Class C drugs and four months for forgery, all to run concurrently and suspended for 24 months. Additionally, she must complete 200 hours of community service for her role in the illegal supply of diazepam, zolpidem, and zopiclone.

'Community pharmacy is far too important to be allowed to wither away' desc-Thousands of pharmacies took part in the second day of the 'Save Our Pharmacies' protest organised by the National Pharmacy Association (NPA) on Thursday. Similar to the first day of protest in June, pharmacies carried out several symbolic actions, such as blacking out windows, to warn of the threat of future closures. Meanwhile, NPA chief executive Paul Rees led a delegation of pharmacy leaders to deliver a 350,000-strong petition to No 10 Downing Street, calling for "immediate, fair and sustained funding to safeguard NHS pharmacy services and ensure local pharmacies have a future." The delegation included NPA Chair Nick Kaye; Janet Morrison, CEO of Community Pharmacy England (CPE); Malcolm Harrison, CEO of Company Chemists' Association (CCA), and Gerard Greene, CEO of Community Pharmacy Northern Ireland (CPNI). Steve Race MP, who is the new chair of the All-Party Parliamentary Group on Pharmacy, and Sadik Al-Hassan, one of only two pharmacists in the House of Commons, also joined them.

The topic of death is often a sensitive and somber one, but it is also a reality that we must face. When someone passes away, there are many legal considerations that come into play surrounding their assets, property, and final wishes. Before delving into the specifics, you must first understand that laws and regulations surrounding death and inheritance can vary greatly depending on location. Different countries, states, and even cities may have their own unique set of laws and procedures in place. involved. That's why you need a legal overview to guide you through the process of protecting your rights in the case of death. Wrongful Death Lawsuits and Compensation In the unfortunate event of a wrongful death, where a person dies due to the negligence or misconduct of another, the bereaved family may seek compensation through legal action. Hiring a lawyer for wrongful death is the best course of action to navigate the complex legal process and ensure that your rights are protected. Wrongful death lawsuits can cover a wide range of incidents, from car accidents to medical malpractice. The compensation awarded in these cases may include funeral expenses, lost wages, and loss of companionship. Know that each case is unique and the amount of compensation awarded will depend on the deceased's income and potential earnings, their age, and the extent of their financial support to their dependents.

Over the last few years pharmacy and the role of pharmacy teams has changed dramatically. The introduction of technology and the integration of artificial intelligence (AI) within systems that provide healthcare and support to pharmacies holds great promise; for improving access to health, supporting patient outcomes, and optimising operational efficiency. Currently, the potential use of AI could span the whole of the medicines value chain, from AI-driven drug discovery to personalised medicines and automated dispensing systems. However, the rapid advancement of AI technology does raise several ethical concerns. This article will explore these concerns and how they can be addressed. In previous articles, I have discussed what underpins artificially intelligent machines and the importance of data. Datasets are the foundation on which AI algorithms learn and generate conclusions. The first step to understanding the potential ethical implications of AI across the pharmacy sector is to understand the data that is held within these foundational datasets. Patient privacy and data security AI systems in and outside of the pharmacy sector, which support patient care, rely heavily on vast amounts of medical data (patient medical records, PMR data, etc). However, the collection, storage, and use of such sensitive data can possibly bring significant privacy concerns. GDPR compliance is essential within the UK and ethical questions arise around data ownership, patient consent, and the possibility of data and cybersecurity breaches. As frontline healthcare professionals, we need to be able to support our patients when questions are asked about their data. For example, how can patients be sure their data is used only for its intended purposes? Is anonymised data truly safe from de-identification techniques that could expose private information?

The Royal College of General Practitioners (RCGP) has warned of a potential 'mass exodus' of qualified GPs due to mounting work pressures. A recent RCGP survey found that over 40 per cent of GPs are unlikely to remain in general practice over the next five years, with a quarter stating it is "very unlikely." The situation is particularly concerning in England, with the highest rate of GPs considering leaving the profession reported to be in the East of England and the South East (47 per cent) and the lowest in the North West (36 per cent). Stress was cited as the main factor for leaving the profession, with more than half of respondents indicating that they find the job too stressful. Additionally, 13 per cent of respondents intend to leave the UK and work overseas. Almost 4 out of 10 GPs said they regularly worked more than 40 hours a week despite fewer than 1 in 10 being contracted to do so. The pressures faced by GPs are so severe that 22 per cent report feeling overwhelmed and unable to cope once or twice a week. The College noted that GPs and their teams have delivered an average of 30 million appointments per month in the past year - over 4 million more each month than in 2019 - despite the number of fully qualified, full-time equivalent GPs decreasing by 601 over the same period.

The journey for patients to quit smoking can be challenging, but with the right strategies and support, it is achievable. Smoking cessation is a critical step for patients towards improving overall health and well-being. We caught up with Thorrun Govind, pharmacist, TV health expert and pharmacy lawyer at Brabners for her top tips. Govind notes that smoking is a leading cause of preventable diseases and deaths worldwide. It is associated with numerous health issues, including lung cancer, heart disease, stroke, and chronic obstructive pulmonary disease (COPD). Quitting smoking can significantly reduce the risk of these conditions and improve quality of life. Within weeks of quitting, individuals often experience improved lung function, better circulation, and enhanced sense of taste and smell. Govind advises that; After 20 minutes of quitting your pulse rate, will already be starting to return to normal. After 48 hours of quitting your carbon monoxide levels have dropped to that of a non-smoker. Your lungs are clearing out mucus and your senses of taste and smell are improving. After 1 year your risk of heart attack will have halved compared with a smoker's. This piece explores the various methods and benefits of smoking cessation.

As Chair of the Council of Healthcare Professionals at Asthma + Lung UK, I'm deeply concerned about the invisible threat of air pollution on the health of our communities. It's a crisis that disproportionately affects the most disadvantaged, exacerbating health inequalities. Shockingly, for every 100 people who die from asthma in the UK, 31 are from the most deprived areas, compared to only 12 from the least. Studies have shown that the most economically disadvantaged are often those worst affected by air pollution, particularly because they often live near busy roads and yet are least likely to own a car. Wherever we live, the chance of breathing air that exceeds the World Health Organization's recommended pollution limits is alarmingly high. For the millions of Brits with lung conditions like asthma and COPD breathing in toxic air can harm their health and quality of life. Exposure to air pollution is directly linked to respiratory symptoms, hospitalisations, and the likelihood of developing respiratory diseases, even shortening life expectancy. Yet many people remain unaware of how much polluted air affects them. Often the first point of contact in healthcare, community pharmacists are well positioned to educate patients, especially those in polluted areas, about the impact of air pollution on their health.

Three Wembley drug gang members have been sentenced for their involvement in a large-scale importation and distribution of unregulated pharmaceutical drugs into the UK from India. Salman Ansari, 33, and his wife Juhi Ansari, 32, of Central Road, Wembley, were among the defendants who were found guilty after a six- week trial and sentenced on 25 October at Southwark Crown Court. Salman and another gang member Waqas Saleem, 33, of Sylvia Gardens, Wembley, were found guilty of 12 counts of possession with intent to supply drugs (Class A, B and C), one count of conspiracy to supply Class C and one count of money laundering. While Salman received a six-year prison sentence, Waqas Saleem was sentenced to two and a half years. Juhi was found guilty of one count of money laundering and received a suspended sentence, requiring her to complete 100 hours unpaid work and 25 days rehab. During the operation, the City of London Police seized over 730kg of drugs, including opioids and benzodiazepines, which are commonly misused for their sedation effect and can be fatal when combined.

In a delightful announcement, the University of Brighton has honoured NHS England's Chief Pharmaceutical Officer, David Webb with its prestigious Doctor of Science honorary degree Webb's award is a highlight of the university's graduation ceremony which celebrated the graduation of over 3,400 undergraduate and postgraduate students from 92 countries at the Brighton Centre this week. The accolade recognises Webb's transformative work in the pharmacy services within the NHS, highlighting the profound impact his contributions have had on delivery of healthcare across the UK. Under Webb's leadership, significant advancements have been made in integrating pharmacy into NHS care pathways, improving patient outcomes, and enhancing the role of pharmacists and pharmacy technicians in the healthcare system. Webb expressed his honour stating, "I am delighted to receive the honorary award of Doctor of Science from the University of Brighton in recognition of both my contribution to pharmacy in the NHS"

Despite being more connected than ever, the majority of Europeans are experiencing feelings of loneliness. The STADA Health Report 2024, released on Monday, revealed that over half (52 per cent) of Europeans "always, often or occasionally" feel lonely. Although the younger generation reports the highest levels of overall happiness, they are the ones most affected by this current loneliness epidemic. Nearly two-thirds (63 per cent) of Europeans aged 18 to 35 reported feeling lonely, compared to 41 percent of those aged 55 and older - according to the report, based on a survey of over 46,000 respondents aged 18 to 99 across 32 countries. Extensive screen time is contributing to increased loneliness among younger people. Europeans under the age of 34 are much more likely to spend long hours on their devices (41 per cent) than those aged 35-54 (22 per cent) and those over 55 (13 per cent). The survey found that people who spend a "long" or "fair" amount of time on social media were significantly more prone to feelings of loneliness compared to those who restrict their screen time. Moreover, extensive screen time was also associated with more intense feelings of loneliness.

Personal injury law, being a set of legal provisions and procedures, can often be difficult to understand; however, knowing the fundamentals is an entirely different game and can greatly impact your claim. If you have a small wound or a car accident, understanding your rights as the victim as well as the best course of action to take is essential. This is what you should know if you want to protect yourself. Documentation About Injury The documentation process is very crucial in ensuring that you win a personal injury case. This consists of maintaining receipts for medical expenses, treatment receipts, and any communication made to do with your injury. You can also use photographs as proof, such as pictures of your injuries, the site of the accident, or the extent of the property damage. Additional information in the form of specifications on how the injury has impacted your daily life, employment, and even mental health enhances the application. This kind of evidence can go a long way in pressuring an insurance company or a judge to take your injuries seriously. Every piece of documentation related to the injury is important, but it is critical to have help on how to format it while filing for the claim. A personal injury attorney must be hired as soon as possible because they play a major role in determining the results of the case. It is always recommended to consult with an attorney who has extensive experience handling these types of claims, as it is critical to adhere to all legal guidelines and procedures. Not only can they explain the general legal proceedings to you but they can also do all the negotiations with insurance companies for you and even defend you in court if required to do so.

A new study from the University of Nottingham has highlighted the impact of Fear of Missing Out (FoMO) and information overload on employee mental health, linking these factors to increased burnout in the workplace. The research, conducted by the University's Schools of Psychology and Medicine and recently published in SAGE Open, surveyed 142 employees to explore the 'dark side' of digital working. It found that employees who are worried about missing out on important information and updates, as well as those overwhelmed by the constant flow of information, are more likely to suffer stress and burnout. Elizabeth Marsh, a PhD student from the School of Psychology, highlighted: "The digital workplace is now recognised as a key strategic asset in organisations that enables worker productivity and flexibility in context of hybrid working. However, the potential downsides in terms of worker well-being also need to be considered, especially given the proliferation of digital communication channels and tools since Covid." The study's findings support the team's previous research, which indicated employees who are more mindful in the digital workplace are better protected against stress, anxiety and overload. Traditionally, FoMO has been associated with social media. Now, this new research has shown its impact in the workplace.

Professor Anthony Harnden has officially commenced his role as chair of the Medicines and Healthcare products Regulatory Agency (MHRA). During his first 100 days, Professor Harnden plans to engage extensively with MHRA staff and partner organisations to gain a strong understanding of "how to drive forward the strategic direction of the MHRA to maintain the UK as a global centre of excellence in life sciences, in the best interests of patients and the public." The new MHRA chair has highlighted three primary areas of focus: Protect patient safety through robust safety surveillance systems Embrace risk-proportionate regulation Foster an inclusive workplace where people flourish. With a 40-year career in the NHS, including 33 years as a general practitioner in Wheatley, Oxfordshire, Professor Harnden brings a wealth of experience to the role. He is a professor of primary care at the University of Oxford. Until December 2024, he was also a registrant council member of the General Medical Council and chair of the Remuneration Committee.

Researchers at the University of Oxford have received a grant of up to £600,000 from Cancer Research UK to develop the world's first vaccine to prevent ovarian cancer. Named OvarianVax, the innovative vaccine aims to train the immune system to recognise and attack the earliest stages of ovarian cancer. Ovarian cancer is the sixth most common cancer among women in the UK, with approximately 7,500 new cases diagnosed annually-equating to about 21 cases each day. It is also a leading cause of cancer-related deaths in women, with around 4,100 deaths each year, accounting for five per cent of all cancer deaths in UK females. Projections suggest that by 2038-2040, there could be around 9,400 new cases of ovarian cancer annually in the UK. Several factors influence a person's risk of developing ovarian cancer, including age, genetics, hormone replacement therapy (HRT), smoking, asbestos exposure, medical conditions such as endometriosis or diabetes, and obesity. Faults in the inherited genes, particularly BRCA1 and BRCA2, are linked to a higher risk of ovarian cancer, contributing to 5-15 per cent of cases.

The Professional Standards Authority for Health and Social Care (PSA) has found that the General Pharmaceutical Council (GPhC) met 17 out of 18 of its Standards of Good Regulation during 2023-24. The GPhC's performance and that of other regulators is reviewed regularly by the PSA, with the results reported to the parliament. This year's report covers the period from 1 July 2023 to 30 June 2024. The PSA concluded that the GPhC has still not met Standard 15 relating to timeliness of fitness to practise (FTP) investigations. The regulator missed this standard last year too. "We note the GPhC's work to reduce the time it takes to progress cases through its FTP system and are aware of the pressure caused by another significant increase in the number of FTP referrals. However, because timeliness has deteriorated this year, we have concluded that Standard 15 is once again not met," the PSA report said. "We have written to the Secretary of State for Health and Social Care and the Chair of the Health and Social Care Committee to provide an update on the GPhC's performance, and we will continue to closely monitor the GPhC's performance in this area."

As part of its commitment to enhancing business performance and ensuring safe, effective pharmaceutical care, Numark has developed 12 guiding principles to help its members in adapting to evolving skill sets and shaping their future. Numark's future model for community pharmacy practice presents an ambitious vision for the sector, focusing on delivering a range of clinical services, enhancing the health of local populations, and becoming an integrated part of primary care. Harry McQuillan, Chairman of Numark, reveals that these principles were derived from changes in pharmacy education, such as the integration of prescribing into undergraduate courses. He views these principles as a formal recognition of the skills that pharmacists and pharmacy teams have developed over time, particularly in the area of independent prescribing. "These principles formalize those evolving capabilities of pharmacists, especially in independent prescribing," McQuillan tells Pharmacy Business.

Burnout is a state of physical, emotional, and mental exhaustion caused by prolonged stress. It can affect anyone, regardless of their profession or personal situation. Recognizing the warning signs of burnout is crucial for taking proactive steps to address it before it leads to more severe health issues. This article will explore the key indicators of burnout and provide practical strategies for managing and preventing it. Physical Symptoms of Burnout Physical symptoms are often the first signs of burnout. These symptoms can manifest in various ways, including chronic fatigue, insomnia, headaches, and muscle tension. Persistent fatigue, even after a full night's sleep, is a significant red flag. This type of exhaustion can make daily tasks feel overwhelming and unmanageable. Insomnia, or difficulty sleeping, is another common physical symptom. Individuals experiencing burnout may find it hard to fall asleep or stay asleep, leading to a vicious cycle of fatigue and sleeplessness. Headaches and muscle tension, particularly in the neck and shoulders, are also prevalent. These symptoms are often caused by the body's prolonged stress response, which keeps muscles in a constant state of tension.

This year has been another turbulent year for the UK pharmacy sector. The sector continues to undergo significant transformations, driven by evolving healthcare needs, regulatory shifts, and economic pressures. For pharmacy owners, staying abreast of these trends is crucial to navigating the challenges and seizing opportunities. IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence, delves into the key issues, challenges, and developments shaping the sector, drawing insights from the latest industry data and reports, supported with data released by NHS England (NHSE). The community pharmacy landscape remains unsettled, with disruptive market dynamics at play. The decline in the number of pharmacies, particularly within the Managed Chains channel, underscores the volatility of the market. The number of active pharmacy contractors in England has dropped significantly, with more closures than openings each month, exacerbated by the exit of Lloyds Pharmacy from the UK market which completed at the end of 2023. In the year ending June 2024, there was a net closure of 440 sites within NHSE which equates to a 4% decline in available pharmacies1. The increase in closures from June 2023 was driven by the closures of Lloyds in Sainsburys and the ongoing divestment of the Boots estate.